The mesenchyme plays a crucial regulatory role in organ formation and maintenance. However, comprehensive molecular characterization of these cells is lacking. We found unexpectedly that primary mesenchyme, as well as mesenchymal cell clones, express T cell receptor (TCR)ab mRNAs, lacking the variable region. Immunological and genetic evidence support the expression of a corresponding TCRb protein. Additionally, mRNAs encoding TCR complex components including CD3 and z chain are present. A relatively higher expression of the mesenchymal TCRb mRNA by cultured mesenchymal cell clones correlates with fast growth, whereas poorly expressing cells are slow growers and are contact inhibited. The clones that express relatively higher amount of the TCR mRNA exhibit an increased capacity to form tumors in nude mice. However, the expression of this mRNA in the mesenchyme is not per se leading to tumorigenesis, as demonstrated by primary mesenchyme that does not form tumors in mice while expressing moderate amounts of the TCR transcripts. The expression of mesencymal TCRb was con®ned to the G2/M phases of the cell cycle in the MBA-13 mesenchymal cell line. This cell cycle dependent expression, considered together with the correlation between growth properties and the level of TCR expression by cell clones, implies association of mesenchymal TCR with cell growth control.
Introduction
The mesenchyme plays a pivotal role in dynamic biological processes of early embryonic development and tissue organization, such as regeneration (for review, Wallace, 1981) , bone modelling (Snell, 2000) , wound healing (Dvorak, 1986) and tumorigenesis (Van den Hoo, 1988) . In the steady state, tissue integrity and structure is similarly governed by the mesenchymal stroma. Adult tissues contain mesenchymal stem cells capable of dierentiating into bone, cartilage, muscle and fat (Pittenger et al., 1999) . Despite the vast knowledge gained on the biology of mesenchyme, only little is known on the molecular mechanisms that govern mesenchymal functions. Recent studies on the gene expression pro®le of mesenchymal stem cells showed abundant expression of gene markers that specify the cell lineages that result from mesencyhmal dierentiation, thus re¯ecting their developmental potential (Tremain et al., 2001) . Here, we show that the mesenchyme expresses components of the T cell receptor (TCR) complex. This ®nding is unexpected both from the current knowledge on mesenchymal dierentiation potentials and also since TCR gene expression is expected to be a T lymphocyte trait. In addition, we ®nd that the expression of TCR gene products appears to relate to the mesenchymal proliferative capacity. It would be of major importance to elucidate the growth control mechanisms that modulate mesenchyme growth in view of the potential of these cells as a source for tissue and organ engineering (Caplan and Bruder, 2001) . Adult bone marrow is a good source for mesenchymal stem cells, and these may be propagated in vitro. Bone marrow transplantation into patients suering from osteogenesis imperfecta, in an attempt to correct this inborn bone defect, indicated contribution of the transplanted cells to the mesenchymal tissues of the host (Horwitz et al., 1999) . Further attempts at using mesenchymal stem cells for tissue regeneration, or for gene therapy, will require better understanding of the molecules, TCR being one candidate, that govern mesenchymal dierentiation and growth.
T cells express surface TCRa and b chains which are structurally similar; both have a variable (V) and a constant (C) region. The junction between the V and C regions is encoded by the joining (J) segment gene and, in the case of b chain, also by the diversity (D) gene segment. Whereas the assembly of the C and J regions requires splicing events, recombination events govern the choice of the V region. TCR gene recombination is performed by the enzymes RAG-1 and RAG-2. T cells are further characterized by numerous molecules involved in the TCR signaling cascade (Shinkai et al., 1992) . TCRab molecules co-localize on T cell surfaces with additional nonvariant membrane proteins including the CD3 complex and the z chain, as well as CD4 and CD8. This TCR complex speci®cally binds processed peptide antigens associated with major histocompatibility complex (MHC) molecules. The interactions of TCR with MHC-bound peptides on various target cells results in either T cell proliferation, apoptosis, energy, or activation of eector mechanisms (for review, Hilyard and Strominger, 1995) .
While expression of the TCR is accepted to be a T cell speci®c trait, partial TCR transcripts have been detected in B cells (Calman and Peterlin, 1986) . Recently, a TCRg mRNA translated from an alternate reading frame has been identi®ed in epithelial cells. The encoded protein is albeit distinct from TCRg (Essand et al., 1999; Wolfgang et al., 2000) . It is therefore possible that the TCR gene family serves functions other than those already ascribed to it. Our study implicates TCR in the regulation of mesenchymal cell growth. A better understanding of the molecular mechanisms regulating mesenchymal cell proliferation will open a new way to control the organization of normal, as well as tumor tissues.
Results

Cultured mesenchymal cell lines express TCRab mRNAs
In a previous study we used RT ± PCR to examine TCR gene usage in T cells that preferentially adhere to a mesenchymal cell line derived from mouse bone marrow (MBA-13 cells) (Barda-Saad et al., 1999) . Unexpectedly, mRNA from the control MBA-13 cells, cultured without T cells, ampli®ed using TCR Cb2 region primers, yielded a RT ± PCR product identical in size to that obtained from T cells. cDNA from liver tissue, and from several control cell lines such as preB, plasmacytoma and mastocytoma cells, did not yield such PCR products ( Figure 1a) . We analysed a variety of mesenchymal stromal cell lines derived by us or obtained from other laboratories. Several, but not all mesenchymal cell lines from the bone marrow, yielded RT ± PCR products similar to those found in MBA-13 cells (Figure 1a ). In addition, experiments using primers to Ca consistently suggested the presence of a TCRa chain mRNA in several stromal cell clones. Nevertheless, expression of these two chains was not always concordant in the stromal cell lines e.g. mRNA from the MBA-13 stromal cell line yielded PCR products with both Cb and Ca primers, whereas the MBA-15 osteogenic cell line did not exhibit Cb but was positive for Ca (Figure 1a, d, e) . These TCR gene products were genuine as veri®ed by sequencing. The results were further substantiated by Northern blot analysis of poly (A) + mRNA that detected TCRb (Figure 1b,c) and TCRa (Figure 1f ) transcripts in the MBA-13 stromal cell line. Densitometric analysis suggested a 60-fold lower abundance of the TCR mRNA in mesenchyme compared to thymic cells. The approximate size of the TCRa transcripts in non-hematopoietic cells corresponded to that found in thymic T cells. In contrast, the TCRb mRNA detected in bone marrow mesenchyme was about 1.1 kb as compared to those of 1.0 and 1.3 kb detected in the thymus. We next aimed to examine whether this expression was con®ned to cultured cell lines or whether primary mesenchyme also expresses TCR components.
Primary mesenchyme expresses TCRab mRNAs
Mesenchymal stem cells contained within the bone marrow population give rise to stromal mesenchyme cell layers upon in vitro culture. mRNA from such stromal cultures and from primary mouse embryos ®broblasts (MEF) were both examined by PCR ampli®cation for TCRCab products. Bone marrow mesenchymal cells seeded in vitro and selected by passaging, to remove contaminating hematopoietic cells, showed clear TCRab fragments of the expected sizes (Figure 1a ,e). Similar results were obtained with MEF ( Figure 1a,d ). The PCR data were substantiated by Northern blot analysis that detected TCRb mRNA in MEF (Figure 1c ).
Expression of TCR complex mRNAs by mesenchyme
In addition to expressing a and b chains we found that the MBA-13 cell line and MEF expressed mRNAs for the CD3e, CD3d and z chains. Expression of CD3e transcripts was documented by PCR and Northern blotting (Figure 2a ,b, respectively) and CD3d and the z chain by PCR (Figure 2c ,d, respectively). These data suggest that primary mesenchymal cells as well as cell lines of this origin express TCR complex mRNAs.
No RT ± PCR products were obtained from mesenchymal cell mRNA using primers designed to amplify TCR V to C rearranged regions or RAG-1 and RAG-2 gene sequences (data not shown). These ®ndings along with the fact that clonal populations of long term cultured mesenchymal cells were used in our experiments eliminate the possibility that the TCR transcripts found in the mesenchyme originate from contaminating T cells. The lack of recombinases suggested that mRNA for TCR, in mesenchymal cells, should be of a shorter, unrearranged form, lacking V region sequences. PCR analysis showed that mesenchymal cells express several J segments ( Figure 2e ). Moreover, sequencing of the PCR products veri®ed that in the mesenchymal TCR mRNA species the J segment is correctly spliced to the Cb2 region. Upstream of the exonic J's we detected intronic J sequences that were shorter in TCRb and substantially longer in TCRa (not shown). These ®ndings explain the results of Northern blotting in which the average transcript size of the mesenchymal TCRb (1.1 kb) is shorter compared to that of VDJC rearranged forms found in thymus.
Identification of a mesenchymal cell surface TCR-like antigen
Sequencing data of PCR products from the TCRb transcribed in mesenchymal cells con®rmed that it contains the entire C region as found in T cells. To test whether mesenchymal cells express a TCR protein we used the H57-597 monoclonal antibody that identi®es the C region. Flow cytometric analysis of MEF using these antibodies demonstrated that MEF from wild type mice are clearly positive and express this antigen on the cell surface ( Figure 3 ). By contrast, no similar antigen was observed in MEF from TCRb 7/7 mutant mice, that do not express TCRb mRNA, providing genetic support for the existence of this TCR protein in mesenchymal cells.
High TCRb mRNA expression in fast growing tumorigenic mesenchymal cells and differential expression during the cell cycle
We next aimed at examining the possible relevance of TCR expression by mesenchymal cells to their biological functions. The MBA-13 cell line was single cell cloned by limiting dilutions and each clone was examined for expression of TCRb mRNA. We chose to study one species of mRNA containing Jb2.6 segment which is relatively abundant in the MBA-13 cell line (PCR ampli®ed using the primers Jb2.6intronic and a Cb2 primer, see Materials and methods). It was found that the MBA-13 clones dierentially expressed this TCRb mRNA. Some of the clones did not produce a signal in semi-quantitative RT ± PCR (Figure 2f ) but nonetheless could be induced to express this mRNA following mitogen stimulation or other perturbations (data not shown). It was observed that the highly expressing clones (C4, D10, B10 and G1) were also highly proliferative (Figure 4a ) and continued growth upon con¯uence. The cells that poorly expressed the mRNA (C6, B1 and B7) grew slowly, reached con¯uence at a relatively low concentration and stopped proliferating. The resulting dierences in cell numbers in con¯uent cultures are shown in Figure 4b . Intradermal injection of these stromal cell clones into nude CD1 recipient mice resulted in tumor formation within a few weeks, only in the case of the non-contact inhibited, fast growing clones (D10, B10 and C4) (Figure 4c , left panel). The slow growing clones (C6 and B7) injected into mice formed tumors at a low incidence and at one month following inoculation (Figure 4c, right panel) . The results shown are following inoculation of 10 6 cells per site. Further experiments showed that the time of onset of tumors was cell dose-dependent, but all the fast growing cells developed tumors when injected at 10 4 ± 10 6 cells per site, whereas the slow growers that produced tumors did so only when injected at 10 6 per site (not shown). The correlation between growth properties and expression of TCR led us to examine the expression of mesenchymal TCRb mRNA as a function of the cell cycle. As shown in Figure 2g , this mRNA was abundant in the G2/M phases of the cell cycle. By contrast, the transcript was undetectable in quiescent cells in G0/G1. + mRNA using a TCR Ca-speci®c probe. MEF-mouse embryo ®broblasts, Pr.BMprimary bone marrow. In (b, c and f) the average transcript size is indicated in kb
Discussion
Past histological observations ascribed to the mesenchyme a glue-like function related to the production of extracellular matrix (ECM) components. The term stroma' was coined to further the notion that the mesenchyme is part of the mechanical support that engulfs tissue cells and organizes them in space. It is now evident that the mesenchymal stroma has major regulatory functions. Furthermore, the adult bone marrow contains mesenchymal stem cells endowed with sucient plasticity to allow dierentiation into a variety of tissues (Pittenger et al., 1999) . Mesenchymal stem cells are therefore capable of being a source for various tissue types and, at the same time, of producing mature mesenchyme that controls the growth, dierentiation and spatial organization of other tissue cells. This capacity must be regulated by unique mechanisms that are yet to be unraveled. It is not clear whether the mesenchyme expresses novel regulatory molecules which are not shared by other tissues, and the need for in-depth analyses of molecules that contribute to mesenchymal functions is evident. It is shown here that mesenchymal cells express TCR complex mRNAs including those encoding a and b chains as well as CD3e. It is further possible that the mesenchyme expresses CD3d and z chain mRNAs as indicated by PCR analyses. Furthermore, immunological and genetic evidence imply the expression of a mesenchymal cell surface TCRb protein. The major + mRNA using a CD3e-speci®c probe. (c) RT ± PCR analysis of CD3d expression using CD3d speci®c primers. (d) RT ± PCR analysis of z expression using z speci®c primers. (e) Jb2 gene usage was analysed in thymus and in MBA-13 mesenchymal cells by RT ± PCR, using Jb2.1 to Jb2.6 primers (including the pseudogene Jb2c) and Cb primer 5. (f) The expression of TCRb in the dierent MBA-13 clones was determined by RT ± PCR using the Jb2.6 intronic primer with the Cb primer 3. (g) mRNA was isolated from MBA-13 cells in the G0/G1, S and G2/M phases of the cell cycle and was examined by semi-quantitative RT ± PCR for the expression of TCRb as in (f) (®rst row). Normalization of cDNA was performed using 18S rRNA primers (second row) with the indicated vectors ®ndings presented in this study are based on the use of a mesenchymal-stromal cell line derived from mouse bone marrow designated, MBA-13. These results are further substantiated by examination of additional bone marrow cell lines from our laboratory as well as cell lines obtained from other investigators. More importantly, these ®ndings are con®rmed in primary stroma from mouse bone marrow and embryo ®broblasts, indicating possible relevance to the mesenchyme in general.
Primary mesenchyme and cloned cell lines express TCRb mRNA at a relatively lower level compared to thymic T cells. The mRNA identi®ed in this study is structurally dierent from successfully rearranged TCRb; a J segment is correctly spliced to the Cb2 but upstream of the J segment no V region sequences were detected. Rather, the mesenchymal TCRb mRNA contained intronic Jb sequences upstream of the 5' end of the J segment. The transcript size observed in Northern blots is about 1.1 kb which corresponds to the truncated nature of the transcript. Since we did not ®nd any evidence for expression of either RAG-1 or RAG-2 in mesenchymal cells, it is expected that the truncated TCR mRNA originates from transcription initiating 5' of the J gene segment. Northern blot analysis of thymocyte TCRb mRNA reveals two major species; one with an average molecular weight of 1.3 kb, encoding the mature form of the b chain, and a second transcript of 1.0 kb which is thought to represent an immature type of the TCRb. Sequence analysis indicated that the 1.0 kb transcripts lack V region sequences (Yoshikai et al., 1984) . In addition, several studies on T and B cells reported the presence of spliced, un-rearranged TCR transcripts lacking the V region, but these were apparently incomplete or contained stop codons (Calman and Peterlin, 1986; Qian et al., 1993; Yoshikai et al., 1984) . Such truncated transcripts have been found in early T cells (Ossendorp et al., 1992; Sutton et al., 1998) , NK cells and gd lymphocytes (Fagioli et al., 1991) . Moreover, a truncated immunoglobulin (Ig) mRNA encoding a surface protein was identi®ed in pre B cells (Reth and Alt, 1984; Tsubata et al., 1991) . This lead to the assumption that germline transcription of the Ig superfamily may have functions which are not associated with the activity of the recombinase machinery (Van Ness et al., 1981) . The regulatory mechanisms that control the usage of intronic sequences in TCR mRNAs that may encode putative alternative versions of the protein, have been widely studied (Qian et al., 1993; Sutton et al., 1998) . Furthermore, usage of germline sequences in other alternatively spliced proteins like bFGF have been identi®ed (Eisemann et al., 1991) .
Since the mesenchyme is widely represented in most organs and tissues, it is possible that the presence of mesenchymal TCR transcripts may be similarly ubiquitous. Thus, TCR encoded transcripts are not unique to T cells and apparently the TCR gene family may have much broader expression and function ranges than previously realised. TCR transcripts have also been reported in additional cell lineages; TCRa mRNA has been identi®ed in murine kidney (Madrenas et al., 1991 (Madrenas et al., , 1992 (Madrenas et al., , 1994 . In a recent study, no evidence for TCRab or TCRd transcripts or proteins was found in epithelial tumor cells, whereas, a partial TCRg chain mRNA, lacking the V region was detected. This mRNA encodes a 7 kDa nuclear protein, TARP, which is translated from an alternate reading frame and is therefore not homologous to the TCRg protein (Essand et al., 1999; Wolfgang et al., 2000) . By contrast, the identi®cation of a cell surface antigen on mesenchymal cells identi®ed by an antibody to the TCR constant region suggests that the truncated TCRb mRNA may encode a protein which is translated from a reading frame identical to that found in T cells.
It has been shown that a recombinant truncated form of TCRb in which the V region is deleted has oncogenic potential since expression of this molecule as a transgene results in the appearance of a high incidence of T cell lymphomas (Jacobs et al., 1996) . Such a V truncated germline transgene was found to be expressed on the cell surface of T cells and to eect their maturation (Ossendorp et al., 1992) . A truncated from of a Ig heavy chain, Dm protein, has been identi®ed and was found to be expressed at the cell surface and to signal an arrest of preB cell proliferation (Gu et al., 1991) . Our experiments showed a correlation between higher expression of the truncated TCRb and increase tumorigenicity. The highly expressing cells proliferated faster and formed rapidly developing tumors while the clones that poorly expressed this transcript were contact inhibited. They rarely formed tumors which appeared only after a long latency time (Figures 2 and 4) . It is further interesting to note that the stromal cell clone 14F1.1 that does not express TCRb mRNA (Figure 1a) is slow growing and contact inhibited (Zipori and Lee, 1988) and does not form tumors upon inoculation into nude mice (Shoham et al., 2001) . However, the mere expression of this naturally occurring truncated TCRb mRNA transcript in mesenchymal cells is not a marker for oncogenicity; Figure 3 Detection of a mesenchymal cell surface antigen reactive with an anti TCRb antibody. Flow cytometric analysis of MEF from wild type (full black line) or from TCR 7/7 mutant mice (gray line) stained by the H57-597 monoclonal antibodies. The dotted line indicates the isotype control normal mesenchyme expresses truncated TCR mRNA but does not exhibit a tumorigenic phenotype. It is therefore implied that the expression of mesenchymal TCR is tightly regulated and the loss of control may lead to transformation and tumorigenesis.
The mesenchymal TCR lack V region sequences and my therefore be represented in these cells in several molecular forms but in a very small repertoire. Moreover, the lack of V region would mean that cells from the same species may express structurally similar TCR molecules and the cells would therefore not be immunogenic upon transplantation. Our¯ow cytometric data indicate the presence of TCR-like antigen in MEF. The amount of this antigen on mesenchymal cell surface is however by far lower than that detectable in T cells.
The ®nding that mesenchymal TCR is expressed in a cell cycle dependent fashion is a further indication for the possible involvement of TCR in mesenchymal cell growth control. Indeed, cyclin B1 mRNA increases during the S phase 50-fold over the G1 level and peaks in G2/M (Hwang et al., 1995) . Cycline B1 has two transcripts one which is constitutively expressed and the other is expressed predominantly during G2/M (Hwang et al., 1998) . It was found that the level of expression of this molecule is critical for the progression of mitosis (Sciortino et al., 2001) . The inhibitor of apoptosis survivin is similarly preferentially expressed in G2/M and may counteract a default induction of apoptosis that occurs during this cell cycle phases (Li et al., 1998) . We found that the mesenchymal TCRb transcripts are undetectable during G1/G0 while abundant expression is observed in G2/M. Further studies should determine whether this cell cycle phase speci®c expression re¯ects a direct role of the mesenchymal TCR in growth control or whether TCR expression is governed by some cell cycle phase dependent molecule.
Materials and methods
Cell lines
Murine bone marrow-derived stromal cell lines used were, the MBA-13 ®broendothelial, MBA-15 osteogenic, MBA-2.1 endothelial-like and the 14F1.1 preadipocytes (Zipori, 1989) . Other cell lines used were: NIH3T3 embryo ®broblasts, C 2 C 12 myoblasts, 1C8 thymic epithelial cells, MPC-11 plasmacytoma, EL-4 and ST1.1 T cell lymphomas and HeLa human ®broblasts. These cell lines were cultured in DMEM containing 10% FCS. AC-6 BM ®broblasts, AC-11 BM adipocytes and FBMD-1 BM adipocytes, were cultured in RPMI 1640 (Gibco) containing 7% FCS, 2 mM L-glutamine, 5610 75 M 2-mercaptoethanol and 1 mM sodium pyruvate. MC-9 mastocytoma cells were cultured in DMEM supplemented with 10% FCS and D-9 conditioned medium containing IL-3 and IL-4. Single cell cloning was performed as follows: Mitotic cells were collected from subcon¯uent cultures of MBA-13 cells, and seeded in limiting dilutions, one cell per 10 wells, followed by a second limiting dilution.
Primary cell cultures
BM cells were obtained from 7 days old C57B1/6J (OLAC) as previously described (Lee et al., 1996) . 10 7 cells/ml were seeded in DMEM supplemented with 20% FCS (Bio Lab, Israel) and cultured for 4 ± 5 days. The plates were washed and supplemented with fresh medium. After monolayer formation the cells were passaged monthly. MEF were obtained from day 14 gestation C57B1 mouse embryo fragments treated with Trypsin-Versan and EDTA at 378C for 15 min. The supernatant was re-treated with Trypsin for 30 min. The cell suspension was washed several times and cells were seeded at 10 6 cells/ml. The MEF monolayer was treated with Trypsin for 5 min and cells were cultured (2610 5 cells/ml). Thymus and liver cells were obtained from 6 ± 10 week old Balb/c mice.
Northern blotting
Total RNA was extracted using Tri-Reagent (Molecular Research Center, Cincinnati, OH, USA). For Northern blotting, poly (A) + mRNA was obtained using oligo dT magnetic columns (Promega). 2 ± 30 mg mRNA were hybridized with probes from the following regions: TCRCb2, TCRCa, CD3e. Radioactive labeling and hybridization conditions have been previously described (Shav-Tal et al., 2000) .
PCR analysis
The following primers were used: CD3e sense-TGCCCTCT-AGACAGTGACG; CD3e antisense-CTTCCGGTTCCGG-TTCGGA; CD3z sense-AAGATGGCAGAAGCCTACAG; CD3z antisense-TTAATGACACAATGACCTTGC; CD3d sense-GGAACAAATGTTGCTTGTCTGG; CD3d antisense-TCTTGGCAAACAGCAGTCGTA. Primers for the Cb2 gene segment: 1 sense-ATGTGACTCCACCCAAGG-TCTCCTTGTTTG; 2 antisense-AAGGCTACCCTCGTGT-GCTTGGCCAGGGGC; 3 antisense-ATCCTATCATCAG-GGGGTTCTGTCTGCAA; 4 sense-CATCCTATCATCA-GGGGGTTCTGTCTGCAA; 5 antisense-TTCAGAGTCA-AGGTGTCAACGAGGAAGG. Primers for the Ca gene segment: 1 sense-AAGATCCTCGGTCTCAGGACAGCA-CC; 2 antisense-ACTGTGCTGGACATGAAAGCTATGG-ATTCC; 3 antisense-GATTTAACCTGCTCATGACG; Jb2.6intronic-CCCTAAATGGGAGAATACC; Jb2.1exonic-ACTATGCTGAGCAGTTCTTC; Jb2.2exonic-GGGCAG-CTCTACTTTGGTG; Jb2.3exonic-GTGCAGAAACGCTG-TATTTTG; Jb2.4exonic-AAACACCTTGTACTTTGGTGC; Jb2.5exonic-CCAAGACACCCAGTACTTTG; Jb2.6exonic-CTATGAACAGTACTTCGGTC;
Jb2.jexonic-CCCTTG-CCCTGACTGATTG; 18S rRNA sense-GTAACCCGTT-GAACCCCATT; 18S rRNA antisense-CCATCCAATCGG-TAGTAGCG.
Flow cytometry
Cells were stained with the following antibodies: anti-mouse TCRb-FITC (clone H57-597); and hamster IgG isotype standard (Pharmingen); goat anti-hamster IgG-FITC (Jackson); anti-rabbit-PE F(ab) 2 fragment (Jackson). Flow cytometric analysis was performed using a Becton Dickinson FACScan equipped with CellQuest software.
Cell sorting
For cell sorting, MBA-13 cells were stained with 12.5 mg/ml Hoechst-33342 for 1 h at 378C. The plates were washed three times with PBS without Ca 2+ or Mg 2+ . Cells were collected following Trypsin Versan treatment, washed and resuspended in PBS with 1% FCS. Cell sorting was performed on FACSVantage (Becton Dickinson). 6 per site were inoculated intradermally in 200 ml of PBS into 6 ± 8 week old male nude CD1 outbred mice (Olac). Mice were examined daily for a month. Tumors were ®rst visible 7 days post injection. Tumor size was determined by caliber measurements of length, width, and depth and tumor volume (mm 3 ) was approximated using the formula: length6width6depth60.5236. Mice bearing large tumors were killed to prevent unnecessary suering. Local tumors and various organs were examined histologically. Cells rescued from three tumors, chosen at random, were propagated in vitro and showed the expected mesenchymal phenotype.
Statistics
Data are presented as the mean+standard error of the mean.
